UniProt ID | NBPFB_HUMAN | |
---|---|---|
UniProt AC | Q86T75 | |
Protein Name | Neuroblastoma breakpoint family member 11 {ECO:0000305} | |
Gene Name | NBPF11 {ECO:0000312|HGNC:HGNC:31993} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 865 | |
Subcellular Localization | Cytoplasm . | |
Protein Description | ||
Protein Sequence | MVVSAGPWSSEKAEMNILEINEKLRPQLAENKQQFRNLKERCFLTQLAGFLANRQKKYKYEECKDLIKFMLRNERQFKEEKLAEQLKQAEELRQYKVLVHSQERELTQLREKLREGRDASRSLNEHLQALLTPDEPDKSQGQDLQEQLAEGCRLAQHLVQKLSPENDEDEDEDVQVEEDEKVLESSAPREVQKAEESKVPEDSLEECAITCSNSHGPCDSIQPHKNIKITFEEDKVNSSLVVDRESSHDGCQDALNILPVPGPTSSATNVSMVVSAGPLSSEKAEMNILEINEKLCPQLAEKKQQFRSLKEKCFVTQVACFLAKQQNKYKYEECKDLIKSMLRNERQFKEEKLAEQLKQAEELRQYKVLVHSQERELTQLREKLREGRDASRSLNEHLQALLTPDEPDKSQGQDLQEQLAEGCRLAQHLVQKLSPENDNDDDEDVQVEVAEKVQKSSSPREMQKAEEKEVPEDSLEECAITCSNSHGPYDSNQPHRKTKITFEEDKVDSTLIGSSSHVEWEDAVHIIPENESDDEEEEEKGPVSPRNLQESEEEEVPQESWDEGYSTLSIPPERLASYQSYSSTFHSLEEQQVCMAVDIGRHRWDQVKKEDQEATGPRLSRELLDEKEPEVLQDSLDRCYSTPSVYLGLTDSCQPYRSAFYVLEQQRIGLAVDMDEIEKYQEVEEDQDPSCPRLSRELLAEKEPEVLQDSLDRCYSTPSGYLELPDLGQPYRSAVYSLEEQYLGLALDVDRIKKDQEEEEDQGPPCPRLSRELLEVVEPEVLQDSLDVIQLLPVVLNSLTPASPTEVPFMHWRKNMLAFLLTWEKLKRRGRGRKEGEEDQRRKEEGEEKKGKKIKTHHAPGSAAC | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
9 | Phosphorylation | VVSAGPWSSEKAEMN CCCCCCCCHHHHHHH | 31.58 | 29759185 | |
10 | Phosphorylation | VSAGPWSSEKAEMNI CCCCCCCHHHHHHHH | 38.97 | 29759185 | |
32 | Ubiquitination | RPQLAENKQQFRNLK HHHHHHCHHHHHHHH | 36.66 | 29967540 | |
60 | Phosphorylation | NRQKKYKYEECKDLI HHHHHCCHHHHHHHH | 17.55 | 21955146 | |
64 | Ubiquitination | KYKYEECKDLIKFML HCCHHHHHHHHHHHH | 59.87 | - | |
81 | Ubiquitination | ERQFKEEKLAEQLKQ HHHHCHHHHHHHHHH | 54.83 | 29967540 | |
86 | Ubiquitination | EEKLAEQLKQAEELR HHHHHHHHHHHHHHH | 3.14 | 29967540 | |
87 | Acetylation | EKLAEQLKQAEELRQ HHHHHHHHHHHHHHH | 47.35 | 7364301 | |
87 | Ubiquitination | EKLAEQLKQAEELRQ HHHHHHHHHHHHHHH | 47.35 | - | |
96 | Ubiquitination | AEELRQYKVLVHSQE HHHHHHHHHHHCHHH | 22.28 | - | |
96 | Acetylation | AEELRQYKVLVHSQE HHHHHHHHHHHCHHH | 22.28 | 7364309 | |
122 | Phosphorylation | EGRDASRSLNEHLQA CCHHHHHHHHHHHHH | 32.81 | - | |
135 | Ubiquitination | QALLTPDEPDKSQGQ HHHCCCCCCCHHCCC | 57.51 | 29967540 | |
139 | Phosphorylation | TPDEPDKSQGQDLQE CCCCCCHHCCCCHHH | 47.09 | - | |
264 | Phosphorylation | ILPVPGPTSSATNVS CCCCCCCCCCCCCEE | 41.03 | 29978859 | |
265 | Phosphorylation | LPVPGPTSSATNVSM CCCCCCCCCCCCEEE | 22.55 | 29978859 | |
266 | Phosphorylation | PVPGPTSSATNVSMV CCCCCCCCCCCEEEE | 41.41 | 29978859 | |
268 | Phosphorylation | PGPTSSATNVSMVVS CCCCCCCCCEEEEEE | 37.79 | 29978859 | |
271 | Phosphorylation | TSSATNVSMVVSAGP CCCCCCEEEEEECCC | 14.13 | 29978859 | |
275 | Phosphorylation | TNVSMVVSAGPLSSE CCEEEEEECCCCCCC | 18.98 | 22199227 | |
280 | Phosphorylation | VVSAGPLSSEKAEMN EEECCCCCCCHHHCC | 39.32 | 23401153 | |
281 | Phosphorylation | VSAGPLSSEKAEMNI EECCCCCCCHHHCCH | 51.29 | 29978859 | |
331 | Phosphorylation | KQQNKYKYEECKDLI HHHCCCCHHHHHHHH | 17.55 | 21955146 | |
335 | Ubiquitination | KYKYEECKDLIKSML CCCHHHHHHHHHHHH | 59.87 | - | |
352 | Ubiquitination | ERQFKEEKLAEQLKQ HHHHHHHHHHHHHHH | 54.83 | 29967540 | |
358 | Acetylation | EKLAEQLKQAEELRQ HHHHHHHHHHHHHHH | 47.35 | 7364317 | |
358 | Ubiquitination | EKLAEQLKQAEELRQ HHHHHHHHHHHHHHH | 47.35 | - | |
367 | Ubiquitination | AEELRQYKVLVHSQE HHHHHHHHHHHCHHH | 22.28 | - | |
367 | Acetylation | AEELRQYKVLVHSQE HHHHHHHHHHHCHHH | 22.28 | 7364325 | |
393 | Phosphorylation | EGRDASRSLNEHLQA CCHHHHHHHHHHHHH | 32.81 | - | |
406 | Ubiquitination | QALLTPDEPDKSQGQ HHHCCCCCCCHHCCC | 57.51 | 29967540 | |
410 | Phosphorylation | TPDEPDKSQGQDLQE CCCCCCHHCCCCHHH | 47.09 | - | |
509 | Phosphorylation | FEEDKVDSTLIGSSS ECCCCCCCEEECCCC | 28.27 | - | |
552 | Ubiquitination | PRNLQESEEEEVPQE CCCCCCCCCCCCCHH | 69.54 | 21906983 | |
575 (in isoform 2) | Phosphorylation | - | 3.37 | 23090842 | |
576 (in isoform 2) | Phosphorylation | - | 16.65 | 23090842 | |
579 (in isoform 2) | Phosphorylation | - | 33.14 | 23090842 | |
580 (in isoform 2) | Phosphorylation | - | 20.81 | 23090842 | |
627 | Ubiquitination | SRELLDEKEPEVLQD HHHHHCCCCCHHHHH | 77.55 | 21906983 | |
627 | Ubiquitination | SRELLDEKEPEVLQD HHHHHCCCCCHHHHH | 77.55 | 21906983 | |
635 | Phosphorylation | EPEVLQDSLDRCYST CCHHHHHHHHHHCCC | 21.14 | 23186163 | |
658 | Phosphorylation | DSCQPYRSAFYVLEQ CCCHHHHHHHHHHHH | 19.52 | 29978859 | |
661 | Phosphorylation | QPYRSAFYVLEQQRI HHHHHHHHHHHHHHH | 12.11 | 29978859 | |
690 | Phosphorylation | VEEDQDPSCPRLSRE HHCCCCCCCHHHHHH | 45.07 | - | |
702 | Ubiquitination | SRELLAEKEPEVLQD HHHHHHHHCHHHHHH | 73.32 | 21906983 | |
710 | Phosphorylation | EPEVLQDSLDRCYST CHHHHHHHHHHHHCC | 21.14 | - | |
721 | Phosphorylation | CYSTPSGYLELPDLG HHCCCCCCCCCCCCC | 11.01 | - | |
756 | Ubiquitination | VDRIKKDQEEEEDQG HHHHHHHHHHHHHCC | 69.73 | 29967540 | |
805 | Phosphorylation | SLTPASPTEVPFMHW CCCCCCCCCCCCCHH | 47.31 | - | |
822 | Phosphorylation | NMLAFLLTWEKLKRR HHHHHHHHHHHHHHC | 33.45 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of NBPFB_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NBPFB_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NBPFB_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CBY1_HUMAN | CBY1 | physical | 20096688 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...